Thomas Hauser Selected Research

Thomas Hauser Research Topics

Disease

8	Vasculitis (Vasculitides) 11/2017 - 02/2007
7	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 06/2023 - 07/2010
4	COVID-19 04/2023 - 11/2021
2	Glomerulonephritis 08/2022 - 11/2017
2	Neoplasms (Cancer) 10/2018 - 08/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 08/2011
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 02/2007
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2017 - 06/2004
2	Squamous Cell Carcinoma of Head and Neck 05/2014 - 05/2013
2	Fibrosis (Cirrhosis) 08/2007 - 01/2007
2	Systemic Scleroderma (Systemic Sclerosis) 08/2007 - 01/2007
1	Infections 04/2023
1	Breakthrough Infections 10/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Reinfection 11/2021
1	Adenocarcinoma 09/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Prediabetic State (Prediabetes) 10/2017
1	Overweight 10/2017
1	Coronary Disease (Coronary Heart Disease) 10/2017
1	Type 2 Diabetes Mellitus (MODY) 10/2017
1	Inflammation (Inflammations) 10/2017
1	Microscopic Polyangiitis 01/2017
1	Rheumatic Diseases (Rheumatism) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2015
1	Chest Pain (Chest Pains) 04/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2015
1	Myocardial Infarction 04/2015
1	Acute Coronary Syndrome 04/2015
1	Lymphatic Metastasis 05/2014
1	Carcinoma (Carcinomatosis) 05/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2013
1	Aneurysm (Aneurysms) 05/2009
1	Thrombosis (Thrombus) 05/2009
1	Polyarteritis Nodosa (Periarteritis Nodosa) 02/2007
1	Necrosis 01/2007
1	Heart Failure 06/2004
1	Leukemia 08/2003
1	Breast Neoplasms (Breast Cancer) 08/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2003
1	Melanoma (Melanoma, Malignant) 08/2003

Drug/Important Bio-Agent (IBA)

10	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2023 - 02/2007
4	Rituximab (Mabthera)FDA Link 01/2017 - 07/2010
4	Azathioprine (Imuran)FDA LinkGeneric 06/2015 - 07/2010
3	Immunoglobulin G (IgG)IBA 04/2023 - 08/2003
3	VaccinesIBA 04/2023 - 01/2022
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015 - 07/2010
2	Antiviral Agents (Antivirals)IBA 04/2023 - 10/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 04/2023 - 10/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 04/2023 - 10/2022
2	COVID-19 VaccinesIBA 01/2022 - 11/2021
2	AntibodiesIBA 11/2021 - 08/2003
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2017 - 12/2010
2	GlucocorticoidsIBA 06/2015 - 07/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 08/2007 - 01/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2023
1	BNT162 VaccineIBA 10/2022
1	Glucose Transporter Type 1IBA 09/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2021
1	GadoliniumIBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 10/2018
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	AdiponectinIBA 10/2017
1	Glycated Serum ProteinsIBA 10/2017
1	salicylsalicylic acid (salsalate)IBA 10/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Edetic Acid (EDTA)FDA Link 01/2017
1	trans-crotonin (CTN)IBA 04/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015
1	TroponinIBA 04/2015
1	omega-Chloroacetophenone (Mace)IBA 08/2011
1	HydrogelsIBA 05/2009
1	PolymersIBA 05/2009
1	PlatinumIBA 05/2009
1	CytokinesIBA 08/2007
1	indium-bleomycinIBA 08/2007
1	theasinensin AIBA 08/2007
1	trichostatin A (A 300)IBA 08/2007
1	Biomarkers (Surrogate Marker)IBA 02/2007
1	Proteins (Proteins, Gene)FDA Link 01/2007
1	Imatinib Mesylate (Gleevec)FDA Link 01/2007
1	montelukast (Singulair)FDA Link 06/2004
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 06/2004
1	AntigensIBA 08/2003

Therapy/Procedure

5	Therapeutics 05/2014 - 06/2010
3	Remission Induction 01/2017 - 04/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2015
1	Stem Cell Transplantation 08/2003
1	Immunotherapy 08/2003